8-K: Kimball Electronics Reports Q3 Results, Reaffirms Fiscal 2025 Guidance, and Expands Medical Manufacturing Capacity

Kimball Electronics announced its Q3 fiscal 2025 results, reiterating its full-year guidance and revealing plans for a new manufacturing facility focused on the medical sector.

Summary

• Kimball Electronics reported net sales of $374.6 million for Q3 fiscal 2025.
• Operating income was $11.7 million, representing 3.1% of net sales, with an adjusted operating income of 4.2%.
• The company generated $30.9 million in cash from operating activities, marking the fifth consecutive quarter of positive cash flow.
• Borrowings on credit facilities decreased by $26.2 million from the previous quarter to $178.8 million, a 40% reduction year-to-date.
• Inventory levels were reduced by $9.6 million from Q2 to $296.6 million.
• Capital expenditures totaled $4.0 million, and $3.0 million was invested to repurchase 175,000 shares of common stock.
• Sales in the medical vertical increased by 2%, while automotive and industrial sales declined by 14% and 15%, respectively.
• Kimball Electronics expects to be at the high-end of its fiscal year 2025 guidance, with net sales between $1.40 and $1.44 billion and adjusted operating income between 3.4% and 3.6% of net sales.
• Capital expenditures are estimated to be at the low-end of the guidance range of $40 $50 million.
• A new manufacturing facility in Indianapolis will support the company's medical CMO strategy.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While sales are down year-over-year, the company is managing costs effectively, generating positive cash flow, reducing debt, and expanding into a growth market (medical). The reiteration of guidance also contributes to the positive outlook.

Positives

• Kimball Electronics achieved positive cash flow from operating activities for the fifth consecutive quarter, generating $30.9 million.
• The company reduced its debt by $26.2 million in Q3, bringing the total reduction for the fiscal year to $116 million, or 40%.
• Inventory levels decreased by $9.6 million from the previous quarter.
• The company is expanding its manufacturing capacity with a new facility in Indianapolis focused on the medical industry.
• The company expects to be at the high-end of its fiscal year 2025 guidance for both net sales and adjusted operating income.

Negatives

• Net sales decreased to $374.6 million in Q3 2025 from $425.0 million in Q3 2024.
• Sales in the automotive and industrial sectors declined by 14% and 15%, respectively.
• Open orders decreased to $642 million from $831 million in the same period last year, primarily due to the cancellation of a major automotive program and other demand reductions.

Risks

• The company faces risks related to global economic conditions, geopolitical environment and conflicts such as the war in Ukraine, global health emergencies, availability or cost of raw materials and components, tariffs and other trade barriers, and foreign exchange rate fluctuations.
• The company's ability to convert new business opportunities into customers and revenue is also a risk factor.

Future Outlook

Kimball Electronics expects to be at the high-end of its fiscal year 2025 guidance range for both net sales and adjusted operating income.

Management Comments

• Im proud of the results for the third quarter and our teams ability to navigate an environment of uncertainty, while focusing on what is controllable.
• This is another step of repositioning the Company for a return to growth and expanding our medical CMO strategy.

Industry Context

Kimball Electronics' expansion in the medical CMO sector aligns with the growing demand for outsourced manufacturing services in the healthcare industry. The company's focus on this high-growth market positions it to capitalize on favorable industry trends.

Comparison to Industry Standards

• Kimball Electronics competes with other EMS and CMO providers such as Jabil, Flex, and Sanmina.
• The company's adjusted operating income margin of 4.2% is within the range of its peers, but there is room for improvement to reach the higher end of the industry standard.
• The company's focus on the medical sector is similar to strategies employed by competitors seeking higher-margin opportunities.

Stakeholder Impact

• Shareholders may be encouraged by the positive cash flow, debt reduction, and share repurchase program.
• Employees may benefit from the company's expansion and focus on growth markets.
• Customers in the medical sector may see improved service and capacity with the new facility.
• Suppliers may experience changes in demand based on the shifts in vertical market sales.

Next Steps

• The company will hold a conference call and webcast on May 7, 2025, to discuss the Q3 results.
• Kimball Electronics will continue to focus on expanding its medical CMO strategy with the new facility in Indianapolis.
• The company will work towards achieving the high-end of its fiscal year 2025 guidance.

Key Dates

Keywords

Kimball Electronics, EMS, CMO, manufacturing, financial results, earnings, guidance, medical, automotive, industrial